Introducing the F3 Platform Biologics Team

The F3 Team is comprised of experts with decades of experience in research and development of amifostine applications, a proven track record of successful execution and performance in a variety of companies, from start-ups to large publicly traded institutions, a history of successfully commercializing scientific products, extensive medical practice and specialization in radiation physics, radiation oncology, medical oncology and cancer treatment, and deep experience in managing both start-up and established pharmaceutical companies

Executive Team

Jonathan Peskoff

Chief Executive Officer & Co-Founder

Mr. Peskoff has more than 25 years of experience maximizing value and guiding organizational growth for companies as an executive officer, entrepreneur, senior investment banker, venture capitalist and individual investor …

Read More >

James R. Miller

Executive Vice President & Co-Founder

James R. Miller has held senior executive positions in large pharmaceutical/biotechnology companies including: Vice President & General Manager, Talecris Biotherapeutics; Vice President, International, Medimmune/Astra …

Read More >

Kevin M. Rooney

Business Consultant

Mr. Rooney has worked with F3 Platform Biologics as a commercial strategy consultant since 2022 Mr. Rooney has been the President of Beacon Consulting Group, a commercial strategy consultancy, since 2007 …

Read More >

Board of Directors

Daniel Courchesne, Chairman

Daniel Courchesne has served as a director since October 4, 2019. Mr. Courchesne is currently President of Synovus’ Specialty Finance Division which includes the Asset Based Lending, Structured Lending and Global One divisions of Synovus Bank …

Read More >

Scientific Advisory Team

Dr. David Grdina

Co-Chair

Dr. David Grdina, co-chair of our SAB, is an expert in the field of radiation biophysics and heads the Grdina Laboratory at the University of Chicago…

Read More >

Dr. David I. Rosenthal

Co-Chair

Dr. David I. Rosenthal is a Professor of Radiation Oncology and Head & Neck Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas…

Read More >

Dr. David Brenner

Dr. Brenner studied radiation physics at the Medical College of St. Bartholomew’s Hospital, University of London, and obtained a PhD from the University …

Read More >

Dr. Winston Marshall

Dr. Marshall is a board-certified cardiologist in the areas of cardiovascular disease and interventional cardiology …

Read More >

Dr. Archie Bleyer

Dr. Bleyer is renowned for his pediatric oncology medical contributions. A University of Rochester School of Medicine and Dentistry graduate …

Read More >

Dr. Jeffrey Murley

Jeffrey S. Murley, PhD is a Research Associate and Associate Professor in the Department of Radiation and Cellular Oncology at The University of Chicago …

Read More >

Dr. Richard Albertini

Dr. Albertini is a Research Professor in the Department of Pathology at the University of Vermont. He has been a professor in the pathology field for …

Read More >

Dr. Donald P. Frush

Dr. Frush is the John Strohbehn Professor of Radiology, and an Associate Faculty Member, Medical Physics Graduate Program at Duke University Medical Center …

Read More >

Dr. Michael I. Koukourakis

Dr. Koukourakis is a Professor of Radiation Oncology, and Head of the Department of Radiotherapy and Oncology, Medical School, Democritus University of Thrace …

Read More >

Dr. Randall A. Stenoien

Dr. Stenoien is CEO of Houston Medical Imaging with 8 locations in the greater Houston area and the Rio Grande Valley. Dr. Stenoien has a vast knowledge of interventional and oncology experience …

Read More >

Dr. James Dziadziola Jr.

Dr. James Dziadziola Jr. is an otolaryngologist in Kannapolis, North Carolina and is affiliated with multiple hospitals in the area …

Read More >

Mr. Viren Grover

Mr. Viren Grover joined our Scientific Advisory Group in 2019, bringing a wealth of experience of more than 40 years …

Read More >

Dr. Ralph Boccia

Dr. Ralph Boccia is the President and Medical Director of the Center for Cancer and Blood Disorders, in Bethesda, Maryland. Dr. Boccia also holds positions as Clinical Associate Professor …

Read More >

Strategic Alliances

University of Chicago

F3 has a worldwide, exclusive license to amifostine-related intellectual property developed at the University of Chicago by the co-chair of our Scientific Advisory Board (“SAB”), Dr. David Grdina …

Read More >